This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
TPG RE Finance Trust (TRTX) Reports Next Week: What Awaits?
by Zacks Equity Research
TPG RE Finance Trust (TRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cushman & Wakefield (CWK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Cushman & Wakefield (CWK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cushman & Wakefield (CWK) Could Beat Earnings Estimates Again
by Zacks Equity Research
Cushman & Wakefield (CWK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cushman & Wakefield (CWK) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 15.38% and 2.17%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CBRE Group (CBRE) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CBRE Group's (CBRE) Q4 results reflect the benefits from the expansion of its resilient business in recent years despite the challenging macro environment.
Vornado (VNO) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Although Vornado (VNO) has premium office assets in key markets, its Q4 performance is likely to be affected by the choppy office real estate market environment and high interest expenses.
Key Factors to Impact Boston Properties' (BXP) Q4 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q4 earnings. However, higher interest expenses might have hurt the company.
Key Factors to Impact Prologis (PLD) This Earnings Season
by Zacks Equity Research
Prologis' (PLD) Q4 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, though high supply might partly limit the growth tempo.
Cushman & Wakefield (CWK) Tops Q3 Earnings Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 5% and 2.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Key Factors to Impact Boston Properties' (BXP) Q3 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q3 earnings. However, higher interest expenses might have hurt it.
CBRE Group (CBRE) Q3 Earnings Beat on Resilient Business Growth
by Zacks Equity Research
CBRE Group's (CBRE) Q3 results reflect the benefits of diversification and the expansion of its resilient business in recent years despite the challenging macro environment.
Vornado (VNO) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Healthy demand for Vornado's (VNO) premium office assets is likely to have benefited its Q3 earnings. However, higher interest expenses are anticipated to have hurt it.
Earnings Preview: Newmark Group (NMRK) Q3 Earnings Expected to Decline
by Zacks Equity Research
Newmark Group (NMRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Cushman & Wakefield (CWK) Q3 Earnings Expected to Decline
by Zacks Equity Research
Cushman & Wakefield (CWK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Factors to Impact Prologis (PLD) This Earnings Season
by Zacks Equity Research
Prologis' (PLD) Q3 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, though high supply might partly limit the growth tempo.
New Strong Sell Stocks for October 6th
by Zacks Equity Research
DIOD, CWK and D have been added to the Zacks Rank #5 (Strong Sell) List on October 6, 2023.
Company News for Sep 15, 2023
by Zacks Equity Research
Companies in The News Are: HPQ, BRK.B, SMTC, MRNA, CWK
Cushman & Wakefield (CWK) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 4.76% and 2.25%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Newmark Group (NMRK) Misses Q2 Earnings Estimates
by Zacks Equity Research
Newmark Group (NMRK) delivered earnings and revenue surprises of -21.74% and 4.04%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CBRE Group (CBRE) Q2 Earnings & Revenues Beat, Decline Y/Y
by Zacks Equity Research
CBRE Group's (CBRE) Q2 results reflect the benefits of diversification and the expansion of its resilient business in recent years. However, severely constrained capital availability affects its sales revenues.
CBRE Group (CBRE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CBRE (CBRE) delivered earnings and revenue surprises of 6.49% and 2.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Cushman & Wakefield, Simon Property, Equity Residential, W. P. Carey and American Homes 4 Rent
by Zacks Equity Research
Cushman & Wakefield, Simon Property, Equity Residential, W. P. Carey and American Homes 4 Rent are included in this Analyst Blog.
4 REITS Likely to Turn Out Winners This Earnings Season
by Moumita C. Chattopadhyay
With the REIT industry offering a real estate structure for several economic activities ¿¿¿ real or virtual ¿¿¿ there are pockets of strength. This is likely to be reflected in the earnings releases of SPG, EQR, WPC and AMH.
Earnings Preview: RE/MAX (RMAX) Q2 Earnings Expected to Decline
by Zacks Equity Research
RE/MAX (RMAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Offing for Vornado (VNO) This Earnings Season?
by Zacks Equity Research
While healthy demand for Vornado's (VNO) premium office assets is likely to have aided its Q2 earnings, an overall choppy U.S. office market and high interest expenses are likely to have marred it.